More about

Ichthyosis

News
August 24, 2024
1 min read
Save

Phase 3 study of TMB-001 for treatment of congenital ichthyosis fails to meet endpoints

Timber Pharmaceutical’s study investigating the use of a new topical ointment formulation of isotretinoin for moderate to severe congenital ichthyosis did not achieve its endpoints, LEO Pharma announced in a press release.

News
February 17, 2024
1 min read
Save

New scoring system demonstrates reliability in live evaluation of ichthyosis severity

The Ichthyosis Scoring System demonstrated robust reliability for both in-person and photographic scoring of ichthyosis severity, according to a study.

News
April 14, 2023
3 min read
Save

Topical isotretinoin ointment shows ‘reassuring’ efficacy, safety in congenital ichthyosis

Two formulations of a novel topical isotretinoin ointment formulation were associated with improvements over vehicle in patients with two types of congenital ichthyosis, according to a study.

News
March 12, 2020
1 min read
Save

Aldeyra to focus on late-stage ocular disease programs

Aldeyra Therapeutics will prioritize its ocular disease programs while placing on hold clinical development in other fields as part of a strategic prioritization program, according to a press release.

News
February 04, 2020
1 min read
Save

Patients with ichthyosis more likely to have depression, anxiety

The effect of ichthyosis on mental health in children and adults leads to a higher prevalence of depression and anxiety, according to a research letter published in the Journal of the American Academy of Dermatology.

News
August 15, 2019
1 min read
Save

Specific genotypes may affect alopecia severity in congenital ichthyosis

Patients with congenital ichthyosis and TGM1 and ABCA12 genotypes may be prone to more extensive alopecia, according to a research letter in JAMA Dermatology.